• 1
    Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin resistant Staphylococcus aureus carrying Panton–Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978984.
  • 2
    Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993; 25: 97108.
  • 3
    Nimmo GR, Coombs GW, Pearson PC et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184: 384388.
  • 4
    Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis 2003; 7: 259267.
  • 5
    Munckhof WJ, Nimmo GR, Carney J et al. Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. Eur J Clin Microbiol Infect Dis 2008; 27: 355364.
  • 6
    Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis 2005; 24: 384387.
  • 7
    Holmes A, Ganner M, McGuane S, Pitt TL, Cookson BD, Kearns AM. Staphylococcus aureus isolates carrying Panton–Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 2005; 43: 23842390.
  • 8
    Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of S. aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505520.
  • 9
    Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant S. aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39: 971979.
  • 10
    Vlack S, Cox L, Peleg AY et al. Carriage of methicillin-resistant Staphylococcus aureus in a Queensland indigenous community. Med J Aust 2006; 184: 556559.
  • 11
    Australian Bureau of Statistics. 2001 census data by location. Available at: (last accessed 6 March 2008).
  • 12
    Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the northern territory. Med J Aust 1996; 164: 721723.
  • 13
    Klevens RM, Morrison MA, Fridkin SK et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006; 12: 19911993.
  • 14
    Millar BC, Loughrey A, Elborn JS, Moore JE. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus. J Hosp Infect 2007; 67: 109113.
  • 15
    Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997; 41: 11371139.
  • 16
    Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests, 9th edn. Approved standard M2-A9. Villanova, PA: CLSI, 2006.
  • 17
    Huygens F, Inman-Bamber J, Nimmo G et al. Staphylococcus aureus genotyping using novel real-time PCR formats. J Clin Microbiol 2006; 44: 37123719.
  • 18
    Robertson GA, Thiruvenkataswamy V, Shilling H et al. Identification and interrogation of highly informative single nucleotide polymorphism sets defined by bacterial multilocus sequence typing databases. J Med Microbiol 2004; 53: 3545.
  • 19
    Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38: 10081015.
  • 20
    Moellering RC. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med 2006; 144: 368369.
  • 21
    Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonisation with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43: 59925995.
  • 22
    Van Duijkeren E, Wolfhagen MJ, Heck ME, Wannet WJ. Transmission of a Panton–Valentine leukocidin positive, methicillin-resistant Staphylococcus aureus strain between humans and a dog. J Clin Microbiol 2005; 43: 62096211.
  • 23
    Ringberg H, Petersson AC, Walder M, Johansson PJH. The throat: an important site for MRSA colonisation. Scand J Infect Dis 2006; 38: 888893.
  • 24
    Bischoff WE, Wallis ML, Tucker KB, Reboussin BA, Sheretz RJ. S. aureus nasal carriage in a student community: prevalence, clonal relationships and risk factors. Infect Control Hosp Epidemiol 2004; 25: 485491.
  • 25
    Graham PL, Lin SX, Larson EL. A US population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006; 144: 318325.
  • 26
    Kuehnert MJ, Kruszon-Moran D, Hill HA et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. J Infect Dis 2006; 193: 172179.
  • 27
    Armstrong-Esther CA, Smith JE. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol 1976; 3: 221227.
  • 28
    Rountree PM. Staphylococci harboured by people in western highlands of New Guinea. Lancet 1956; 270: 719720.
  • 29
    Therapeutic Guidelines Limited. Therapeutic guidelines: antibiotic. North Melbourne, Victoria, Australia: Therapeutic Guidelines Limited, 2006, version 13.
  • 30
    Melles DC, Gorkink RF, Boelens HA et al. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 2004; 114: 17321740.
  • 31
    Wertheim HF, Van Leeuwen WB, Snijders S et al. Associations between Staphylococcus aureus genotype, infection, and in-hospital mortality: a nested case–control study. J Infect Dis 2005; 192: 11961200.
  • 32
    Boyle-Vavra S, Ereshefsky B, Wang C, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J Clin Microbiol 2005; 43: 47194730.
  • 33
    Voyich JM, Otto M, Mathema B et al. Is Panton–Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194: 17611770.